Top Markets
#1 QuantixAI QuantixAI +64.43%
#2 MowCat MowCat +29.30%
#3 UnifAI Network UnifAI Network +29.29%
#4 GEKKO GEKKO +28.60%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +28.02%
#6 MarsCoin MarsCoin +27.38%
#7 Prom Prom +26.92%
#8 Kinesis Silver Kinesis Silver +24.26%
#9 SuperVerse SuperVerse +20.20%
#10 Pons Pons +17.74%
Coin of the day
QuantixAI QuantixAI
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classifica tra le azioni #20488
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$20.35
Capitalizzazione di mercato
$128.91M
Variazione (1 giorno)
-0.96%
Variazione (1 anno)
80.66%
Paese
PL
Scambia Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Healthcare
Ricavi di Captor Therapeutics Spolka Akcyjna (CTX)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Captor Therapeutics Spolka Akcyjna, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Captor Therapeutics Spolka Akcyjna da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH